Although mounting evidence has suggested that the association of low vitamin D with non-skeletal conditions may have widespread health implications, these findings still need to be confirmed by carefully designed observational studies [4] . Risk factors, such as skin pigmentation, living at higher latitudes (above 35°N or below 35°S), excessive use of sunscreen, completely covering the body with clothes, sedentary behaviors, tendency toward staying indoors all the time, obesity, body weight/body mass index (BMI), old age, chronic disease, atmospheric pollution, and genetics, leading to vitamin D deficiency primarily involve inadequate exposure to sunlight [3] . The presence of vitamin D receptor (VDR) in most body tissues indicates its broader physiological role beyond calcium and bone metabolism [5] .
Vitamin D deficiency is an epidemic in India affecting 50-90% of the population with varying degrees of insufficiency [6] . India is located near the equatorial region and the climate in India and other South Asian countries is sunny throughout the year, thereby creating ample possibilities of exposure to sunlight. However, due to the dark skin pigmentation, people living in Indian subcontinents require double amount of UVB exposure to produce the same amount of vitamin D as compared to white Europeans [7] . A high prevalence of vitamin D deficiency is reported across the country among people in all age groups, both genders, lower to upper socio-economic status [8] , urban and rural populations [9, 10] , pregnant women and their new born [11] , postmenopausal women [12] , and young healthy adults [13] . However, a majority of these studies comprise a very small number of study participants (ranging from 12 to 150) [14, 15] . Despite the high prevalence of cardiometabolic disease and vitamin D deficiency in India, there is paucity of data showing the relationship between vitamin D status and cardiometabolic traits in the Indian population.
Accumulating evidence from animal and human studies suggest that hypovitaminosis D may contribute to pancreatic beta cell dysfunction and insulin resistance, and hence to type 2 diabetes (T2D) [16] . Currently, 62.4 million people in India have T2D and 77.2 million have prediabetes [17] , accounting for the highest prevalence after China [18] . Vitamin D levels are easily determined by measuring the level of circulating calcidiol (25[OH] D) in blood, which depends on exogenous supply through dietary sources, endogenous production in the skin, and the overall activities of vitamin D metabolic enzymes. We have previously reported a very high prevalence of vitamin D deficiency among 1,765 individuals (887 T2D patients and 878 controls) from Punjab, India. Vitamin D deficiency was found to be increased in proportion to T2D, obesity, and CVD risk factors [15] . To gain insight into the effects of vitamin D deficiency present within the population, in this study, we report the association of gender differences in serum vitamin D deficiency with increased risk for cardiometabolic traits in our extended cohort comprised of 3,879 Asian Indians (2,198 T2D and 1,681 controls) . In this study, we have also included UVB index data to adjust for the confounding effects of seasonal changes that may influence vitamin D concentrations. To our knowledge, this is the first comprehensive study on Asian Indians reporting the role of vitamin D status on cardiometabolic health with possible gender-specific health implications.
Experimental Methods

Study Population
Participants for this study were recruited as part of the Asian Indian Diabetic Heart Study (AIDHS)/Sikh Diabetes Study (SDS) [19, 20] . The AIDHS is a population-based, cross-sectional study originally aimed to investigate the genetic and environmental factors responsible for a high prevalence of metabolic syndrome, T2D, and early cardiovascular disease in Punjabi Sikhs. A total of 3,879 adult participants of age >25 years were analyzed in this study. Sikhs are strictly a nonsmoking population and 50% of participants were teetotalers and lifelong vegetarians. The diagnosis of T2D was made based on medical records for symptoms or use of medications or diabetes was defined on the basis of the measured fasting glucose levels following the American Diabetes Association guidelines [21] . The selection of controls was based on a fasting blood glucose (FBG) <100.8 mg/dL or glucose during oral glucose tolerance test <141.0 mg/dL. Participants with impaired fasting glucose or impaired glucose tolerance were excluded from the study. Insulin was measured by radio-immuno assay (Diagnostic Products, Cypress, USA). Homeostasis model assessment for insulin resistance (HOMA-IR) was calculated using the formula, fasting insulin (μIU/mL) × fasting glucose (mmol/L)/22.5 as described previously [22] . BMI was calculated using the formula, weight (kg)/height (meter) 2 . Waist and hip circumferences were measured with a tape at the abdomen and at the hip levels. The World Health Organization (WHO) has recommended lower BMI thresholds for Asian populations; therefore, obesity was defined using WHO's new guidelines [23] ; participants with BMI <23 kg/m 2 were classified as "normal weight," those with BMI between 23 and 27.5 kg/m 2 were classified as "overweight," and those with BMI >27.5 kg/m 2 were classified as "obese." Details on assessing the levels of physical activity, smoking, alcohol consumption, and diet are described elsewhere [19, 20, 24] . In general, Sikhs do not smoke due to religious and cultural reasons, and about 50% of the study participants are lifelong vegetarians. Blood pressure (BP) was measured twice after a 5 min seated rest period. To remove the confounding effects of seasonal variation on vitamin D synthesis, UVB index data were collected for each recruitment site. The quantum of UVB rays (290-310 nm) received by each individual was computed from the publicly available data either in Tropospheric Emission Monitoring Internet Service (http://www.temis.nl/uvradiation/GOME/ stations.html) or in National Weather Service, (http://www.cpc. ncep.noaa.gov/products/stratosphere/uv_index/uv) corresponding to the month and year of recruitment.
All blood samples were obtained at the baseline visit. All participants provided informed consent following procedures approved by Institutional Review Boards (IRBs). All AIDHS/SDS protocols and consent documents were reviewed and approved by the University of Oklahoma Health Sciences Center IRB as well as the Human Subject Protection (Ethics) Committees at the participating hospitals and institutes in India.
25(OH) Vitamin D Measurements
25(OH)D levels were quantified on fasting serum using standard monoclonal antibody-based ELISA kits from ALPCO Diagnostics (Salem, NH, USA) as we reported previously [15, 25] . Samples were run in duplicate following the manufacturer's instructions.
Statistical Analysis
Group descriptive statistics was expressed as mean ± SD. Serum 25(OH)D levels were analyzed as a continuous variable after log transformation or as a categorical variable either as deficient (<30 nmol/L) or sufficient ( ≥ 30 nmol/L). Vitamin D status was classified as "deficient" and "sufficient" based on the recommendation of the Institute of Medicine, Food and Nutrition Board [26] and as described recently [27] .
Variables with skewed distributions were log transformed (e.g., 25 [OH]D, FBG, fasting insulin, and HOMA-IR). Independent t tests were used to analyze the association between serum 25(OH) D and BMI (normal/overweight/obese groups) to evaluate the effect of vitamin D deficiency on quantitative traits. The classification of BMI was based on BMI cut points recommended by WHO Expert Consultation for Asian populations as described above [23] . The association of serum vitamin D with cardiomatabolic traits was evaluated by multivariate regression analysis performed separately on T2D cases and normoglycemic controls. In addition to age, gender, and BMI, UVB index was also included as covariates to remove the confounding effects of seasonal variation. Regression analysis was modeled for the interaction effect of BMI and serum vitamin D level on cardiometabolic traits including FBG, fasting insulin, HOMA-IR, HOMA-B, systolic BP, and diastolic BP using data from normoglycemic controls. Gender differences (male/female) for continuous traits (e.g., age, BMI) were analyzed using the Student t test ( Table 1 ) and for categorical variables, the vitamin D status (sufficient/deficient) was assessed using the χ 2 test ( Fig. 1 ). Bonferroni correction p value for rejecting the null hypothesis for ( n ) number of test at α = 0.05 was calculated using (α/ n ).
All analyses were performed using SPSS for windows statistical package (IBM SPSS Statistics for Windows, version 20.0; IBM Corp, Armonk, NY, USA).
Results
Clinical characteristics of the study population, stratified by T2D and vitamin D status, are summarized in Table 1 . Of the 3,879 individuals analyzed, 55% were men and 57% had T2D. The mean age of the participants was 51.9 ± 13.2 years. Vitamin D deficiency was highly prevalent in this population. In this study, a total of 58% men and 51% women participants were classified as having the deficient vitamin D status (<30 nmol/L; Fig. 1 ). The distribution of serum vitamin D level was significantly different between the men and women participants ( p = 1.1 × 10 -5 ). Serum 25(OH)D levels were inversely correlated with obesity and were significantly reduced in overweight (BMI 23-27.5 kg/m 2 ; p < 0.0001) and obese (BMI >27.5 kg/m 2 ; p < 0.001) individuals ( p trend < 0.0001; Fig. 2 a) in T2D and even among healthy normoglycemic controls ( Fig. 2 b) . This association remained significant ( p < 0.02) in male and female participants separately ( Fig. 2 b) . Notably, mean 25(OH)D levels remained consistently reduced among male participants irrespective of obesity and T2D status ( Table 1 ; Fig. 2 a, b) .
Further, we evaluated the association of vitamin D status on obesity and cardiometabolic traits using Pearson's correlations and multivariate linear regression analysis on normoglycemic individuals ( Table 2 ; online suppl. Table 2 ; for all online suppl. material, see www.karger. com/doi/10.1159/000458765). The analysis was adjusted for the confounding effects of age and UVB index as appropriate. A highly significant association of serum vitamin D was mainly observed with BMI (β = -0.56, p = 1.2 × 10 -7 ) in combined samples, and this association remained significant in both male (β = -0.67, p = 4.6 × 10 -6 ) and female (β = -0.42, p = 0.007) participants; the strength of association was more pronounced in men. While a significant association of HOMA-IR with vitamin D was seen only in females ( p = 0.008), only marginal significance was observed in HOMA-B. Taken together, the observed strong association of serum vitamin D with BMI in normoglycemic participants suggests that vitamin D deficiency and obesity may together have an additive effect for influencing the extent of cardiometabolic risk.
We, therefore, further performed interaction analyses to assess the contribution of serum vitamin D and obesity (BMI) in normoglycemic individuals for impacting other cardiomatabolic risk traits including FBG, fasting insulin, HOMA-IR, HOMA-B, and systolic and diastolic BP. Only FBG and HOMA-B showed significant association in vitamin D and BMI interaction analysis (online suppl. Table 1 ). As shown in Table 3 Table 3 ). Taken together, cardiometabolic risk traits including FBG and HOMA-B level were modulated by the BMI and serum vitamin D interactions, and this effect was mainly confined to men among the normoglycemic individuals.
Discussion
The relationship between obesity and 25(OH)D has been consistently reported and well established [15, [28] [29] [30] . Our study confirms a strong inverse association of serum 25(OH)D with BMI, and this inverse association with BMI remained consistently significant in both men and women when analyzed separately ( Fig. 2 ) . However, in gender-separated analysis in each BMI subgroup (normal/ overweight/obese), vitamin D levels remained significantly reduced in men when compared to women, irrespective of obesity and T2D. Vitamin D is a fat-soluble hormone and its absorption is enhanced in obesity. Previously it was thought that obesity can lead to the sequestration of vitamin D in adipose tissue, thus reducing its bioavailability [31] . However, recent studies by Drincic et al. [32] could not find any evidence of sequestration of supplemental or endogenous 25(OH)D in fat cells. Their findings suggested that the dosing for vitamin D in obese patients should be adjusted according to body size and not according to BMI to achieve desired serum 25(OH)D concentrations [33] . Arguably, hyperparathyroidism, secondary to hypovitaminosis D, augmented by obesity, could also be responsible for the observed association with obesity [34] . Largely, the obese people with T2D and a CVD risk profile are generally less active and may be less exposed to sunlight. Therefore, the possibility of reverse causation of vitamin D deficiency among the obese could also not be ruled out. Indeed, a large study on 42,024 individuals reported a causal link between vitamin D deficiency and obesity using a bi-directional genetic approach -the Mendelian Randomization -using 12 BMI-related single nucleotide polymorphisms. Their findings suggested that higher BMI leads to lower 25(OH)D, whereas the contribution of lower 25(OH) D levels for increasing obesity would likely be small [35] .
Also, in our study, the fasting glucose levels were increased with vitamin D deficiency in patients with T2D, but a significant increase was not observed in healthy normo-glycemic controls (online suppl. Table 1 ). In contrast BMI, body mass index; BP, blood pressure; FBG, fasting blood glucose; HOMA-IR, homeostasis model assessment for insulin resistance; HOMA-B, homeostasis model assessment of β-cell function; R 2 , R-squared for each model and their p values, B ± SE = unstandardized coefficient with standard error and their p values after adjustment with covariates; to remove the confounding effects of seasonal variation, UVB index were used as covariate for adjustment in addition to age, BMI, and gender where appropriate (covariates: * adjusted for age, BMI, UVB index, gender; ^ adjusted for age, BMI, UVB index; $ BMI was not used as covariate while analyzing BMI as a trait). Significant p values are shown in boldface. $ p values remain significant even after adjustment with alcohol consumption in male participants. to the NHANES data for 2005-2010, which showed that men tend to have a higher FBG [36] , in AIDHS, we observed that the FBG levels were comparable between nondiabetic healthy men (95.4 mg/dL) and women (94.6 mg/ dL) when the sample was not stratified by vitamin D status. However, FBG was significantly increased and HOMA-B was significantly decreased in obese individuals with vitamin D deficiency, as revealed in interaction analysis performed in normoglycemic controls ( Table 3 ) . These data are in line with the existing evidence that vitamin D plays a critical role in insulin secretion and insulin action [16, 37] , and that vitamin D status may influence the progression to risk for cardiomatabolic disease including T2D through BMI [37] . Notably, in gender-specific analysis, this observation was restricted to male participants among normoglycemic individuals ( Table 3 ) . Although the inverse association of 25(OH)D with fasting glucose and insulin has been shown earlier in non-Hispanic whites and Mexican Americans in NHANES, differences according to gender were not reported [38] . A number of earlier studies have reported the direct or indirect effect of vitamin D to insulin response either through the receptors or vitamin D concentrations influencing the gene function in the pathway for insulin secretion [39] [40] [41] [42] [43] . Sex-specific confounders, such as endogenous testosterone secretion, may account for differences in the effect of low 25(OH)D in males and females, since vitamin D is known to effect androgen synthesis in testicular cells [44] , and possibly ovarian androgens with high testosterone levels in women [45] . Several earlier studies have reported an increase in 25(OH)D levels in women who are on oral contraceptives [46] [47] [48] . Also, earlier studies have independently confirmed the positive association of vitamin D and testosterone levels [49, 50] and vitamin D supplementation increases testosterone levels in men [49] . To our knowledge, a vast majority of our participants (particularly women) were not on hormonal therapy and this finding was based on their clinical reports or self-reported medication details. Importantly, VDRs and vitamin D metabolizing enzymes (CYP2R1, CYP27B1, and CYP24A1) are widely expressed in human testis [51, 52] . The VDR knockout mice have exhibited significant gonadal insufficiency and decreased sperm count and motility [51, 53] . Gender difference in the skeletal phenotype was also displayed in male mice lacking VDR gene [54] . Also, the low vitamin D status is associated with increased diabetes risk in hypo gonadal men [55] . Our own study of telomere length revealed that Sikh men had significantly shorter telomere length compared to Sikh women, and shorter telomere length was associated with significantly increased risk of cardiomatabolic diseases [20] . The other possible explanation for gender-specific association could be the difference in alcohol intake between men and women. Indian women (Sikh) do not consume alcohol due to cultural and religious reasons. Prolonged alcohol consumption among men reduces the absorption and activation of vitamin D [56, 57] . Moreover, worldwide prevalence rates of CVD-related mortality are higher in men including Asian Indians [55, 58, 59 ] . Therefore, further studies will be needed to understand the implicit link between hypogonadism (specifically lower testosterones), vitamin D insufficiency, and cardiomatabolic disease outcomes in men. We also observed the significant association of serum vitamin D level with obesity and cardiometabolic traits in an entire cohort; and an analysis based on T2D status revealed that the observed association was mostly mediated by diabetes. However, in normoglycemic participants, it appears that in vitamin D deficiency, interaction with obesity may further compound the total risk of cardiomatabolic diseases by increasing FBG by reduced beta cell function (HOMA-B). Oh et al. [60] found that the active form of vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with T2D. Therefore, a direct protective effect of vitamin D on the improved beta cell function and endothelium is possible, since vitamin D deficiency has been associated with impaired beta cells and endothelial dysfunction [61] .
Our study has both strengths and weaknesses. This is the first large comprehensive study reporting the role of serum vitamin D deficiency in cardiometabolic health in a population from South Asia. Furthermore, our data of 25(OH)D levels have been adjusted for seasonal changes that may influence vitamin D status during the winter months. Individuals on vitamin D supplementation were excluded from the study. Some limitations of our study include the case-control and cross-sectional study design and lack of data on testosterone and estrogen levels in the study participants. In summary, the results from our findings suggest that vitamin D deficiency may significantly enhance the risk of cardiometabolic disease in Asian Indians. Since Asian Indians, particularly men, are known to be susceptible to the metabolic syndrome, T2D, and early coronary artery disease [19, 22, 62] , vitamin D deficiency may put them at additional risk, making a strong case for early intervention, especially in obesity. Future randomized control trials and genetic studies would clarify the mechanism underlying the gender differences in vitamin D deficiency, and whether vitamin D-driven improvement in testosterone may contribute to beneficial cardiomatabolic outcomes in men.
